We are live on ! Find out more
WM

WS Management Portfolio holdings

AUM $1.13B
1-Year Est. Return 53.44%
This Fund
S&P 500
This Quarter Est. Return
+9.29%
1 Year Est. Return
+53.44%
3 Year Est. Return
+163.58%
5 Year Est. Return
+226.76%
10 Year Est. Return
+868.14%
AUM
$1.17B
AUM Growth
+$63.4M
Cap. Flow
-$11.1M
Cap. Flow %
-0.96%
Top 10 Hldgs %
60.24%
Holding
91
New
19
Increased
9
Reduced
12
Closed
24

Top Sells

Rank Stock Value
1
NEM icon
Newmont
NEM
+$13.9M
2
MU icon
Micron Technology
MU
+$10M
3
COP icon
ConocoPhillips
COP
+$7.9M
4
CNQ icon
Canadian Natural Resources
CNQ
+$4.8M
5
UBER icon
Uber
UBER
+$3.83M

Sector Composition

Rank Sector Weight
1 Financials 13.77%
2 Energy 4.32%
3 Technology 4.25%
4 Materials 3.83%
5 Consumer Staples 3.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LCID icon
51
CALL
Lucid Motors
LCID
$2.52B
$4.1M 0.35%
60,000
+20,000
+50% +$2.2M
CLF icon
52
Cleveland-Cliffs
CLF
$6.58B
$3.25M 0.28%
+201,500
New +$3.03M
BMRN icon
53
BioMarin Pharmaceuticals
BMRN
$11.8B
$3.2M 0.27%
30,953
SPR
54
DELISTED
Spirit AeroSystems
SPR
$2.96M 0.25%
+100,000
New +$2.6M
HA
55
DELISTED
Hawaiian Holdings, Inc.
HA
$2.74M 0.24%
267,021
ASA
56
ASA Gold and Precious Metals
ASA
$954M
$1.75M 0.15%
122,351
WVE icon
57
Wave Life Sciences
WVE
$1.15B
$1.35M 0.12%
192,722
MPT
58
Medical Properties Trust
MPT
$2.91B
$1.11M 0.1%
+100,000
New +$1.16M
NTLA icon
59
Intellia Therapeutics
NTLA
$1.51B
$930K 0.08%
26,646
CRSP icon
60
CRISPR Therapeutics
CRSP
$4.66B
$767K 0.07%
18,876
RARE icon
61
Ultragenyx Pharmaceutical
RARE
$2.67B
$736K 0.06%
15,885
SLN
62
Silence Therapeutics
SLN
$563M
$381K 0.03%
25,000
EDIT icon
63
Editas Medicine
EDIT
$416M
$255K 0.02%
28,797
CVNA icon
64
CALL
Carvana
CVNA
$45.4B
$237K 0.02%
+250,000
New +$528K
AMC icon
65
AMC Entertainment Holdings
AMC
$2.12B
$233K 0.02%
+5,714
New +$360K
AFMD
66
DELISTED
Affimed
AFMD
$124K 0.01%
10,000
FSR
67
PUT
DELISTED
Fisker Inc.
FSR
$105K 0.01%
14,500
-150,000
-91% -$1.12M
ADAP
68
DELISTED
Adaptimmune Therapeutics
ADAP
-115,602
Closed -$124K
BA icon
69
Boeing
BA
$167B
-23,932
Closed -$2.9M
BLUE
70
DELISTED
bluebird bio
BLUE
-561
Closed -$71K
CAT icon
71
CALL
Caterpillar
CAT
$395B
-50,000
Closed -$8.2M
CHWY icon
72
CALL
Chewy
CHWY
$9.07B
-20,000
Closed -$614K
CLF icon
73
CALL
Cleveland-Cliffs
CLF
$6.58B
-200,000
Closed -$2.69M
CLLS
74
Cellectis
CLLS
$286M
-50,907
Closed -$117K
CNQ icon
75
Canadian Natural Resources
CNQ
$94B
-206,168
Closed -$4.8M

Similar funds

WS Management's Q4 2022 Portfolio in Review

As of Q4 2022, WS Management held 91 positions worth $1.17B, up 5.8% from $1.1B the previous quarter. Its ten largest holdings account for 60% of the portfolio.

WS Management's Q4 2022 filing shows 19 new, 9 increased, 12 reduced and 24 closed positions. Its largest new stake was VanEck Gold Miners ETF: 599,100 shares worth $17.2M. The largest sale was Newmont, an estimated $13.9M.

By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 13% a quarter earlier, followed by Energy and Technology.

  • WS Management's largest Q4 2022 buy was VanEck Gold Miners ETF: 599,100 shares worth $17.2M.
  • WS Management added most to Invesco QQQ Trust in Q4 2022, an estimated $27.3M increase.
  • WS Management's biggest Q4 2022 reduction was Micron Technology, cutting an estimated $10M.
  • WS Management fully exited Newmont in Q4 2022, selling an estimated $13.9M.
  • WS Management's ten largest holdings make up 60% of its $1.17B portfolio in Q4 2022.
  • WS Management opened 19 new positions and closed 24 in Q4 2022.
  • WS Management's portfolio value rose 5.8% quarter-over-quarter to $1.17B.

Based on WS Management's 13F filing for Q4 2022, filed 14 Feb 2023.